ABOUT
Proprietary blend of botanicals from SOLGEN soybean isoflavones and Cucurbita pepo.
Contains high levels of genistin & genistein isoflavones, the phytoestrogen that favorably contributes in menopause urinary incontinence
Genistein therapy regressed the degenerative changes associated at OAB symptoms*(2).
Proprietary clinical studies in European women*(3-7)
WHY
73% reduction of urine leakages*(4)
46% reduction of urge urinary incontinence episodes*(3)
52% reduction of stress incontinence episodes (SUI)*(4)
69% reduction in nocturia*(5,6)
60% reduction in volume of nocturnal diuresis*(5)
66% reduction in daily panty-liners*(4)
GMP manufacturing (Tradichem Industrial Services)
DOSAGE
2 x 500mg for the first 4 weeks.
1 x 500mg for the following 20 weeks.
*(1): Claim on hold
*(3-7): Propietary clinical studies